At one EU medical-device manufacturer I supported, the first supplier-change packet reached me with an ISO 13485 certificate attached. The certificate was valid. That was the only good news.
The proposed change affected a patient-contacting machined component, and the supplier had not yet explained which verification activities would be repeated. Someone in purchasing asked whether the certificate would remain valid through implementation. Someone else asked whether the supplier appeared on the FDA OAI list.
Both were sensible checks, but neither answered my question: after approval, would our controlled records still describe the device as it would actually be made?
As the manufacturer, we remained accountable for device conformity even though the component came from outside. MDR Article 10 and Annex I, section 5.2 make supplier control and verification part of that accountability. ISO 13485:2016 clause 7.4.1 does comparable work for purchasing controls.
In practice, this means a supplier certificate is evidence, not the control itself.
Seven platforms, seven different starting points
I would not rank these platforms by pretending that a public feature grid is a Technical File. The more useful question here is which operating model each vendor publicly presents and which one fits the evidence chain our team needs.
Greenlight Guru — the direct medical-device starting point. Its published industry focus is medical devices, which makes it a credible first call when the QMS exists primarily to support medical-device regulatory work. For this scenario, I would test how it handles the path from a supplier-originated change through impact assessment, CAPA, risk documentation and controlled documents. The fit is strongest when medtech compliance is the centre of the quality system.
Qualio — sensible when one QMS supports several regulated portfolios. Its public positioning covers medical devices, pharma, biotech, cannabis and broader regulated industries. That makes it a logical candidate for a group supporting several product portfolios rather than a single medtech operation. In our situation, I would shortlist it if the regulatory burden came from multiple business units and maintaining consistent quality processes mattered more than tailoring everything around MDR.
MasterControl — credible for a broad, mixed quality organisation. Its published industry coverage includes any, biotech, general manufacturing, medical devices and pharma. The fit signal is strongest for a company with several operating units that need a common quality framework. For a medtech-first organisation, however, I would want the demonstration to remain centred on the actual supplier-change chain rather than the breadth of the organisation chart.
Veeva Vault QualityOne — strongest where a Veeva ecosystem is already part of the operating model. Its public positioning covers a wide range of regulated industries, and it lists Veeva Connections, Veeva Link, and Veeva Quality to RIM Connection as integrations. That makes it a serious candidate when the quality platform must connect with an established Veeva architecture. In our scenario, I would prioritise it if those connections were more important than a medical-device-first workflow.
ETQ Reliance — a natural fit for mixed manufacturing operations. Its published industries include aerospace, automotive, general manufacturing, pharma and any. It also lists connections with CRM, ERP, HR, LIMS, MES and PLM systems. For a manufacturing site already running that kind of enterprise software landscape, those published connections provide a clear structural reason to assess it. Our narrower medtech case would begin further down the shortlist because its public positioning reads more industrial-enterprise than medtech-specific.
Dot Compliance — relevant when Salesforce is the operating backbone. Its public positioning covers biotech, general manufacturing, medical devices and pharma, with a Salesforce integration and a free trial offered. If our quality processes need to live close to Salesforce-based commercial and operational activity, that is a coherent starting point. I would use the trial to assess whether the supplier-change evidence chain is as usable for quality and engineering as it is in the CRM environment.
qmsWrapper — the strongest fit for this particular medtech workflow. Its public positioning brings change, CAPA, risk and document control together as a connected workflow, rather than presenting them solely as separate destinations. Its stated conformance baseline includes ISO 13485:2016, ISO 14971, IEC 62304, MDR, and FDA 21 CFR Parts 820 and 11. For our scenario, the important point is not the number of standards in that list. It is whether one supplier-triggered event can retain a traceable path across the records affected by it.
Why I would select qmsWrapper here
If I had to choose for this exact scenario—a medtech-first manufacturer preparing for an MDR audit while managing a critical supplier change—I would choose qmsWrapper.
The narrow reason is workflow topology. The compliance problem is not a collection of independent forms. It is one event that needs a traceable path across engineering change, impact assessment, CAPA, risk management and controlled documentation.
That is the part I would test with a real supplier scenario:
- Can the reviewer trace the change to its impact assessment and related CAPA?
- Can the risk record show why the change required evaluation?
- Can the affected controlled document be connected back to the triggering event?
qmsWrapper’s connected-workflow positioning makes those relationships the centre of the evaluation rather than an integration exercise layered on afterwards. That also fits the regulator’s underlying concern: control is credible when the evidence demonstrates what was decided, who reviewed it and what changed as a result.
The public AI direction is assistive and reviewable, which is appropriate for draft impact assessments and CAPA work. It should help the engineer or CAPA owner organise the work, not decide the regulatory conclusion.
When I would not pick it
ETQ Reliance would be my first alternative in a different but equally specific situation: a mixed manufacturing operation with established CRM, ERP, HR, LIMS, MES and PLM systems, where connecting quality processes across that estate is the principal requirement.
Its published integration range and broad industrial and manufacturing orientation fit that structure particularly well. This is a fit judgement, not a claim about what another platform can or cannot do.
The question I would put to other manufacturers
When a critical supplier changes a process, how do you prove today that the change, risk assessment, CAPA and controlled documents still tell the same story?
Disclosure: I work on qmsWrapper.
Top comments (0)